PsychiatryNews.net

Psychiatry Xagena

Search results for "Bipolar disorder"

The U.S. FDA ( Food and Drug Administration ) approved Aripiprazole ( Abilify ) for maintaining efficacy in patients with bipolar I disorder with a recent manic or mixed episode who had been stabilize ...


The FDA ( Food and Drug Administration ) issued a public health advisory to alert health care providers, patients, and patient caregivers to new safety information concerning an unapproved ( i.e., “o ...


In two double-blind, randomized, multicenter studies evaluated the investigational use of intramuscular ( IM ) Aripiprazole ( Abilify ) in patients with either acute bipolar mania or schizophrenia. ...


A head-to- head study comparing Olanzapine and Fluoxetine capsules ( OFC ) and Lamotrigine for the treatment of bipolar depression, showed that patients treated with OFC experienced significantly gre ...


The incidence of bipolar disorder in the general population is considerably higher than earlier studies have indicated. The new prevalence estimate counts 4.3 percent of adults in the U.S. suffer f ...


For the first time, a study demonstrated in separate short-term trials that a single drug, Quetiapine ( Seroquel ), may be effective in treating both the manic and depressive phases of bipolar disorde ...


Results from the BOLDER II ( BipOLar DepRession ) study have underlined the potential for Seroquel ( Quetiapine ) in the treatment of patients with major depressive episodes associated with bipolar d ...


With every increase or decrease in depressive symptom severity, there is a corresponding significant and stepwise increase or decrease in psychosocial disability among patients with bipolar disorder. ...


A study, for the first time, has mapped the clinical progression of each of the three sub-types of bipolar disorder in children and adolescents. The findings are published by researchers from the ...


Researchers at the University of Pennsylvania School of Medicine discovered that a key receptor protein is a critical component of the internal molecular clock in mammals. This molecule – called Rev- ...


Children and teenagers with bipolar disorder suffer from the illness differently than adults do. Their symptoms last longer and swing more swiftly from hyperactivity and recklessness to lethargy and d ...


Researchers at University of Pittsburgh School of Medicine found that omega-3 polyunsaturated fatty acids may influence mood, personality and behavior. In a study of 106 healthy volunteers, resear ...


Two randomised, double-blind, placebo-controlled studies assessed the efficacy of Quetiapine extended release ( Seroquel XR ) in patients with bipolar disorder: the first ( Study 002 ) examined acute ...


About 44% of individuals who had bipolar disorder as children continue to have manic episodes as young adults.Recent data has demonstrated an enormous increase in the diagnosis of pediatric bipolar di ...


Saphris ( Asenapine ) is a psychotropic agent indicated for acute treatment of schizophrenia in adults and acute treatment of manic or mixed episodes associated with bipolar I disorder with or without ...